(Credit-Canva)
Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!
The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.
"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.
The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.
While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.
And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.
Credit: AI generated
Every year on 25 April, World Malaria Day is observed to raise awareness about one of the deadliest yet preventable diseases.
According to the latest World Malaria Report 2025, there were 282 million cases of malaria in 2024, an increase of about 9 million cases (3 per cent) compared with 2023.
The estimated number of malaria deaths stood at 610,000 in 2024 compared to 598,000 in 2023.
With 37 countries reporting fewer than 1,000 cases in 2024, progress at the global level is stalling.
The theme this year is "Driven to End Malaria: Now We Can. Now We Must."
According to the World Health Organization, for the first time, ending malaria seems to be a real possibility, as science is advancing faster than ever with new vaccines, treatments, malaria control tools and pioneering technologies.
That is why the theme "is a rallying cry to grasp the moment—to protect lives now and fund a malaria-free future".
The theme also builds on a strong line of focused global campaigns in recent years that resulted in 47 countries being certified malaria-free.
In the last few years, substantial progress has been made, with an estimated 2.3 billion malaria infections prevented and 14 million lives saved worldwide since 2000.
However, the WHO flagged that the gains are at risk due to multiple challenges, including
The theme also underscores the need to end Malaria by 2030 with coordinated global action. As stronger community health systems have brought the world closer to this goal than ever before, the day presents the need to boost
World Malaria Day was first celebrated internationally in 2008, building upon the earlier "Africa Malaria Day", which had been observed by African countries since 2001. The date, April 25, was established by the WHO in 2007 during the World Health Assembly.
In 2007, it was the 60th session of the World Health Assembly where the proposal to rename Africa Malaria Day to World Malaria Day was made to acknowledge the global presence of malaria.
Read: Thought A Heatwave Could Save You From Malaria? Expert Begs To Differ
The day has a strong significance in healthcare as it brings attention to the disease that still continues to take so many lives, especially in low-income and tropical regions. It also serves as an important reminder to continue spreading awareness about the disease as well as promoting its prevention, treatment, and continuous international cooperation to fight against it.
The WHO describes malaria as a life-threatening disease spread to humans by some types of mosquitoes, mostly found in tropical countries. However, they are preventable and curable.
"Malaria is spread to people through the bites of some infected anopheles mosquitoes. Blood transfusion and contaminated needles may also transmit malaria," as per the WHO.

The first symptoms may be mild, similar to many febrile illnesses, and difficult to recognize as malaria. Left untreated, P. falciparum malaria can progress to severe illness and death within 24 hours.
The WHO notes 5 Plasmodium parasite species that cause malaria in humans.
Symptoms of Malaria
The early symptoms include fever, headache, and chills, which can usually start within 10 to 15 days of getting bitten by an infected mosquito.
Some types of malaria can cause severe illness and death. Infants, children under 5 years, pregnant women, travellers, and people with HIV or AIDS are at higher risk. Severe symptoms include:
World DNA Day: The rise of early illness in India is not just a lifestyle issue. It is the result of a deeper interplay between genetics and environment. (Photo credit: AI generated)
India is witnessing a concerning change in health patterns. Conditions like diabetes, cardiovascular disease, and certain cancers are appearing in higher numbers and at younger ages than in previous generations. While lifestyle factors like diet, stress, and reduced physical activity play a role, there is a deeper, often overlooked driver: genetics.
Dr Ramesh Menon, Director of Personal Genomics and Genomic Medicine, MedGenome, said, "From the discovery of DNA's double helix in 1953 to the completion of the Human Genome Project in 2003, today genomics, the study of our DNA, is helping us uncover these disease risks. Instead of studying DNA in isolation, scientists are using it to understand human health and disease. Why does one person develop cancer while another does not? Why are some people affected by Alzheimer’s early in life? Why do some people respond well to a drug while others experience severe side effects? Genomics is providing answers that matter."
Doctors can now identify genetic mutations linked to conditions like breast cancer, cystic fibrosis, or rare inherited disorders. In some cases, treatments are tailored to a patient’s genetic profile, a concept known as precision medicine. It is also helping reveal how inherited traits can interact with environmental factors to accelerate disease onset, helping identify risks early, enable timely screening, and tailor treatments more precisely. This DNA Day, we turn the spotlight on how understanding our genetics could be key to managing this early disease burden.
Dr Menon said that studies suggest that Indians carry distinct genetic traits that may increase the chances of early onset of diseases. For instance, South Asians are more prone to insulin resistance and tend to develop Type 2 diabetes at a younger age compared to many Western populations. India is already home to over 100 million people living with diabetes, and that number is expected to rise sharply in the coming decades.
Another example is coronary artery disease, which tends to manifest nearly a decade earlier in Indians compared to many Western populations. Genetic variants affect cholesterol transport, inflammation, and arterial wall function, contributing to a higher risk, even among people who may seem to have healthy lifestyles. Similarly, certain cancers, such as breast and colorectal cancers, are increasingly being diagnosed earlier in Indian populations. Inherited genetic mutations linked to cell growth regulation and DNA repair, combined with environmental exposures, can increase the pace of tumour development.
What is more concerning is that a significant proportion of the population remains undiagnosed or is diagnosed at late stages, allowing diseases to progress silently.
Dr Menon explained that just a generation ago, daily life involved far more physical movement, such as walking to work, manual labour, home-cooked meals, and limited access to processed food. Today, most of our routines are reversed. Desk jobs, high screen time, food and grocery delivery at the doorstep, and screen-heavy lifestyles mean many people burn fewer calories while consuming more energy-dense, ultra-processed foods. This imbalance is a key driver behind the increased rate of conditions such as cardiometabolic disorders and cancers.
What is striking is not just the increase in cases but also the decrease in the average age of disease onset. This is especially relevant for what many experts describe as an “F1 generation exposure." Our parents may not have lived with the same levels of inactivity or dietary change. Our genes, however, remain the same. The mismatch between genetic predisposition and rapid lifestyle shifts is where the problem intensifies.
Closing the Gap
In many Indian households, conditions like diabetes or heart disease are spoken about casually. “It runs in the family” is often said and quickly brushed aside. But genetics is not just about inherited risk. It also influences how early that risk shows up. If previous generations developed these conditions in their 50s and 60s, the timeline is now becoming shorter. That shift is subtle, but it is already playing out across India.
Perhaps the most critical gap lies in how we approach prevention. Indians are known to develop certain diseases nearly 8 to 10 years earlier than many Western populations, yet screening timelines often remain unchanged. Most people still begin serious health check-ups in their 40s. By then, metabolic changes may have been progressing quietly for years. The idea that a 30-year-old could already be at risk is still not widely accepted, even though the evidence increasingly suggests otherwise.
The larger shift we need is not just in how we treat disease but in how we anticipate it. Advances in genetic testing and preventive diagnostics now make it possible to identify risk much earlier and act before conditions fully develop. However, awareness remains the missing link. Moreover, health conversations in families are still reactive, not proactive. Something as simple as knowing when a parent was diagnosed or what conditions are common in the family can offer valuable insight into one’s own risk.
Malaria is a major health crisis in India. (Photo credit: AI generated)
World Malaria Day is observed on April 25 every year to raise awareness of the infection, its causes, symptoms, and prevention strategies. At a time when the heatwave is at its most severe, many fall victim to the misconception that rising temperatures could mitigate infection risk. However, according to Dr Anil Ballani, Consulting Physician in Internal Medicine at Lilavati Hospital and Research Centre, this is just a myth.
Malaria is a disease transmitted by mosquitoes, mainly female Anopheles mosquitoes, which transmit parasites of the genus Plasmodium. The term ‘malaria’ is derived from the Italian words “ma laria”, which translates to ‘bad air’. Malaria remains one of the major health problems in India, even though the incidence rate has been brought down from 33 million to 3.2 million in the last three decades.
On World Malaria Day, Dr Ballani explained that, contrary to popular belief, malaria is not just a concern during the monsoon season. Unfortunately, it can occur in summer as well. It is well known that malaria incidence is highest during the rainy season due to stagnant water. However, surprisingly, there is also a surge in malaria cases during the summer season. The hot days of summer act as a precursor, as the warm temperature accelerates mosquito breeding. Also, people tend to store water in drums and buckets during the summer due to shortages, and these serve as perfect breeding grounds for mosquitoes.
High temperatures in summer accelerate the mosquito life cycle and maturation, resulting in increased multiplication of larvae. High humidity and high temperatures in summer create ideal conditions for the mosquito life cycle. Faster maturation of the parasite in the mosquito leads to the rapid spread of malaria. Consequently, the risk of malaria transmission also increases. There is often poor vector control prior to the monsoon, as fumigation usually starts after the monsoon sets in.
Schools are closed during the summer, and children venture out more to play. People spend more time in gardens and parks during the early hours of the day and in the evenings due to cooler temperatures, and all this increases their risk of exposure to mosquito bites. Many people travel to their hometowns and villages during holidays when schools are closed, where the incidence of malaria is higher. Due to warm weather, people avoid wearing full sleeves and long clothing, resulting in greater exposure of the arms and legs and increasing the risk of mosquito bites. All these are precursors to a high incidence of malaria in the summer months.
On World Malaria Day, Dr Ballani answered an important question - can malaria diagnosis be delayed? The expert said that sometimes doctors may delay the diagnosis of malaria because of low suspicion during the summer months. Hence, for proper diagnosis, doctors must maintain a high index of suspicion even during summer months and remain vigilant throughout the year. India aims to eliminate malaria by the year 2030, as guided by the National Framework for Malaria Elimination (NFME), and measures such as maintaining a high index of suspicion will go a long way in making this a reality.
© 2024 Bennett, Coleman & Company Limited